You have 9 free searches left this month | for more free features.

PF-07901801

Showing 1 - 25 of 1,083

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

DLBCL Trial (maplirpacept (PF-07901801), Glofitamab, Obinutuzumab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • maplirpacept (PF-07901801)
  • +2 more
  • (no location specified)
May 30, 2023

DLBCL Trial in San Juan (PF-07901801, Tafasitamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • PF-07901801
  • +2 more
  • San Juan, Puerto Rico
    Auxilio Mutuo Cancer Center
Jan 19, 2023

Lymphoma, Multiple Myeloma Trial in Nagoya, Koto, Yamagata (TTI-622)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • Nagoya, Aichi, Japan
  • +2 more
Jan 20, 2023

Non-Hodgkin Lymphoma, Multiple Myeloma Trial in China (Maplirpacept)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Beijing, Beijing, China
  • +3 more
May 31, 2023

Healthy Participants Trial (Single dose of PF-07220060 as first Tablet Formulation, Single dose of PF-07220060 as second Tablet

Not yet recruiting
  • Healthy Participants
  • Single dose of PF-07220060 as first Tablet Formulation
  • +3 more
  • (no location specified)
Jun 20, 2023

Atopic Dermatitis Trial in United States (PF-07275315, PF-07264660, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • Huntington Beach, California
  • +3 more
Aug 21, 2023

Healthy Trial (PF-07976016, Placebo, Midazolam)

Not yet recruiting
  • Healthy
  • (no location specified)
Oct 24, 2023

Healthy Trial in New Haven, Brussels (PF-07817883, Placebo, Midazolam)

Recruiting
  • Healthy
  • New Haven, Connecticut
  • +1 more
Dec 19, 2022

Hemiparesis;Poststroke/CVA Trial in Créteil (Eccentric training, Conventional therapy)

Recruiting
  • Hemiparesis;Poststroke/CVA
  • Eccentric training
  • Conventional therapy
  • Créteil, France
    Wael Maktouf
Nov 16, 2023

Pulmonary Arterial Hypertension Trial (PF-07868489, Placebo for PF-07868489)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • (no location specified)
Nov 14, 2023

Healthy Trial in New Haven (PF-07328948, Placebo)

Recruiting
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 5, 2023

Presbyopia Trial in Crystal River (BRIMOCHOL™ PF, Carbachol PF, Vehicle)

Recruiting
  • Presbyopia
  • BRIMOCHOL™ PF
  • +2 more
  • Chandler, Arizona
  • +42 more
Sep 30, 2022

Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Jun 7, 2023

Breast Cancer, Solid Tumors Trial in Boston, Grand Rapids, Houston (PF-07220060 + PF-07104091 combination dose escalation,

Recruiting
  • Breast Cancer
  • Solid Tumors
  • PF-07220060 + PF-07104091 combination dose escalation
  • +2 more
  • Grand Rapids, Michigan
  • +1 more
Jun 28, 2022

Healthy Trial (PF-07817883, Itraconazole)

Not yet recruiting
  • Healthy
  • (no location specified)
Apr 10, 2023

Overweight, Obesity Trial in New Haven (Formulation A (PF-07081532 20 mg plus 60 mg), Formulation B (PF-07081532 80 mg))

Recruiting
  • Overweight
  • Obesity
  • Formulation A (PF-07081532 20 mg plus 60 mg)
  • Formulation B (PF-07081532 80 mg)
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 25, 2023

Hemolysis During Pulsed-field and Radiofrequency Ablation

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • Pulsed-field ablation
  • Radiofrequency ablation
  • Prague, Czechia
    Cardiocenter, 3rd Medical School, Charles University and Univers
Oct 20, 2023

Pelvic Floor Disorders Trial in Palma De Mallorca (Pelvic floor muscle training with biofeedback device, Pelvic floor muscle

Not yet recruiting
  • Pelvic Floor Disorders
  • Pelvic floor muscle training with biofeedback device
  • +2 more
  • Palma De Mallorca, Balearic Islands, Spain
    University of the Balearic Islands
Aug 29, 2023

Crohn's Disease Trial in Worldwide (PF-06651600 Placebo, PF-06651600, Placebo PF-06700841)

Active, not recruiting
  • Crohn's Disease
  • PF-06651600 Placebo
  • +3 more
  • Dothan, Alabama
  • +187 more
Aug 17, 2022

COVID-19 Trial in Denmark, United States (PF-07304814, Placebo, Remdesivir)

Suspended
  • COVID-19
  • Chula Vista, California
  • +39 more
Mar 22, 2023

Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer,

Recruiting
  • Locally Advanced or Metastatic ER+ HER2- Breast Cancer
  • +2 more
  • Scottsdale, Arizona
  • +45 more
Dec 11, 2022

Renal Impairment Trial (Drug: PF-07923568)

Not yet recruiting
  • Renal Impairment
  • Drug: PF-07923568
  • (no location specified)
Sep 7, 2023

Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)

Recruiting
  • Advanced Solid Tumors
  • +5 more
  • Scottsdale, Arizona
  • +7 more
Jan 23, 2023

Acne Inversa Trial in Australia, Canada, United States (PF-06650833, PF-06700841, PF-06826647)

Completed
  • Acne Inversa
  • Birmingham, Alabama
  • +76 more
Jul 10, 2022

Healthy Participants Trial in Brussels (PF-07258669, Placebo, Midazolam)

Recruiting
  • Healthy Participants
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
Nov 28, 2022